Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Child and Family Perspectives on Adjustment To and Coping With Pediatric Inflammatory Bowel Disease.

Easterlin MC, Berdahl CT, Rabizadeh S, Spiegel B, Agoratus L, Hoover C, Dudovitz R.

J Pediatr Gastroenterol Nutr. 2020 Mar 5. doi: 10.1097/MPG.0000000000002693. [Epub ahead of print]

PMID:
32142001
2.

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Evaluation and Management for Patients With Very Early-onset Inflammatory Bowel Disease.

Kelsen JR, Sullivan KE, Rabizadeh S, Singh N, Snapper S, Elkadri A, Grossman AB.

J Pediatr Gastroenterol Nutr. 2020 Mar;70(3):389-403. doi: 10.1097/MPG.0000000000002567.

PMID:
32079889
3.

A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.

Jaber MI, Song B, Taylor C, Vaske CJ, Benz SC, Rabizadeh S, Soon-Shiong P, Szeto CW.

Breast Cancer Res. 2020 Jan 28;22(1):12. doi: 10.1186/s13058-020-1248-3.

4.

NASPGHAN Position Paper on The Evaluation and Management for Patients with Very Early-Onset Inflammatory Bowel Disease (VEO-IBD).

Kelsen JR, Sullivan KE, Rabizadeh S, Singh N, Snapper S, Elkadri A, Grossman AB.

J Pediatr Gastroenterol Nutr. 2019 Dec 30. doi: 10.1097/MPG.0000000000002567. [Epub ahead of print]

PMID:
31899730
5.

Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy.

Hicks KC, Knudson KM, Lee KL, Hamilton DH, Hodge JW, Figg WD, Ordentlich P, Jones FR, Rabizadeh S, Soon-Shiong P, Schlom J, Gameiro SR.

Clin Cancer Res. 2020 Feb 1;26(3):704-716. doi: 10.1158/1078-0432.CCR-19-0727. Epub 2019 Oct 23.

PMID:
31645354
6.

Deep Learning Implicitly Handles Tissue Specific Phenomena to Predict Tumor DNA Accessibility and Immune Activity.

Wnuk K, Sudol J, Givechian KB, Soon-Shiong P, Rabizadeh S, Szeto C, Vaske C.

iScience. 2019 Oct 25;20:119-136. doi: 10.1016/j.isci.2019.09.018. Epub 2019 Sep 14.

7.

Correction to: Immunotherapy Utilizing the Combination of Natural Killer- and Antibody Dependent Cellular Cytotoxicity (ADCC)-Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition.

Fenerty KE, Padget M, Wolfson B, Gameiro SR, Su Z, Lee JH, Rabizadeh S, Soon-Shiong P, Hodge JW.

J Immunother Cancer. 2019 Sep 2;7(1):234. doi: 10.1186/s40425-019-0715-9.

8.

Serum HSP70 level in patients with endometrial cancer with and without diabetes.

Heidari F, Rabizadeh S, Sadat Salehi S, Akhavan S, Khaloo P, Alemi H, Mirmiranpour H, Esteghamati A, Nakhjavani M.

Gynecol Endocrinol. 2019 Aug 8:1-5. doi: 10.1080/09513590.2019.1648415. [Epub ahead of print]

PMID:
31392909
9.

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review.

Rabizadeh S, Nakhjavani M, Esteghamati A.

Int J Endocrinol Metab. 2019 Apr 22;17(2):e84353. doi: 10.5812/ijem.84353. eCollection 2019 Apr. Review.

10.

Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy.

Lee KL, Benz SC, Hicks KC, Nguyen A, Gameiro SR, Palena C, Sanborn JZ, Su Z, Ordentlich P, Rohlin L, Lee JH, Rabizadeh S, Soon-Shiong P, Niazi K, Schlom J, Hamilton DH.

Cancer Immunol Res. 2019 Aug;7(8):1359-1370. doi: 10.1158/2326-6066.CIR-18-0620. Epub 2019 Jul 10.

PMID:
31292145
11.

Comparison of primary versus secondary prevention of cardiovascular disease in patients with type2 diabetes: Focus on achievement of ABC goals.

Rabizadeh S, Mansournia MA, Salehi SS, Khaloo P, Alemi H, Mirbolouk H, Blaha MJ, Esteghamati A, Nakhjavani M.

Diabetes Metab Syndr. 2019 May - Jun;13(3):1733-1737. doi: 10.1016/j.dsx.2019.03.043. Epub 2019 Mar 29.

PMID:
31235086
12.

Inflammatory, oxidative stress and anti-oxidative markers in patients with endometrial carcinoma and diabetes.

Heidari F, Rabizadeh S, Mansournia MA, Mirmiranpoor H, Salehi SS, Akhavan S, Esteghamati A, Nakhjavani M.

Cytokine. 2019 Aug;120:186-190. doi: 10.1016/j.cyto.2019.05.007. Epub 2019 May 14.

PMID:
31100682
13.

Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.

Wu J, Lubman DM, Kugathasan S, Denson LA, Hyams JS, Dubinsky MC, Griffiths AM, Baldassano RN, Noe JD, Rabizadeh S, Gulati AS, Rosh JR, Crandall WV, Higgins PDR, Stidham RW.

Am J Gastroenterol. 2019 May;114(5):777-785. doi: 10.14309/ajg.0000000000000237.

PMID:
31058681
14.

Ectopic cushing's syndrome due to corticotropin releasing hormone.

Nakhjavani M, Amirbaigloo A, Rabizadeh S, Rotondo F, Kovacs K, Ghazi AA.

Pituitary. 2019 Oct;22(5):561-568. doi: 10.1007/s11102-019-00965-9. Review.

PMID:
31041631
15.

Loss of Inverse Association between Framingham Risk Score and Estimated Glomerular Filtration Rate in Moderate to Severe Diabetic Kidney Disease.

Khaloo P, Alemi H, Mansournia MA, Rabizadeh S, Salehi SS, Blaha MJ, Mirbolouk MH, Mirmiranpour H, Esteghamati A, Nakhjavani M.

Arch Iran Med. 2019 Feb 1;22(2):91-98.

16.

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma.

Givechian KB, Garner C, Benz S, Song B, Rabizadeh S, Soon-Shiong P.

Oncotarget. 2019 Mar 5;10(19):1840-1849. doi: 10.18632/oncotarget.26748. eCollection 2019 Mar 5.

17.

The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex.

Jochems C, Tritsch SR, Knudson KM, Gameiro SR, Rumfield CS, Pellom ST, Morillon YM, Newman R, Marcus W, Szeto C, Rabizadeh S, Wong HC, Soon-Shiong P, Schlom J.

Oncoimmunology. 2018 Nov 27;8(2):e1532764. doi: 10.1080/2162402X.2018.1532764. eCollection 2019.

18.

Multiparametric liquid biopsy analysis in metastatic prostate cancer.

Hodara E, Morrison G, Cunha A, Zainfeld D, Xu T, Xu Y, Dempsey PW, Pagano PC, Bischoff F, Khurana A, Koo S, Ting M, Cotter PD, Moore MW, Gunn S, Usher J, Rabizadeh S, Danenberg P, Danenberg K, Carpten J, Dorff T, Quinn D, Goldkorn A.

JCI Insight. 2019 Mar 7;4(5). pii: 125529. doi: 10.1172/jci.insight.125529. eCollection 2019 Mar 7.

19.

Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.

Krishnakumar C, Ballengee CR, Liu C, Kim MO, Baker SS, Baldassano RN, Cohen SA, Crandall WV, Denson LA, Dubinsky MC, Evans J, Gokhale R, Griffiths A, Guthery SL, Oliva-Hemker M, Heyman MB, Keljo D, Kellermayer R, Leleiko NS, Mack DR, Markowitz JF, Moulton DE, Noe JD, Otley AR, Patel AS, Pfefferkorn M, Rabizadeh S, Rosh JR, Snapper S, Walters TD, Ziring D, Mondal K, Kappelman MD, Hyams JS, Kugathasan S.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1208-1217. doi: 10.1093/ibd/izy363.

PMID:
30601983
20.

Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition.

Fenerty KE, Padget M, Wolfson B, Gameiro SR, Su Z, Lee JH, Rabizadeh S, Soon-Shiong P, Hodge JW.

J Immunother Cancer. 2018 Nov 29;6(1):133. doi: 10.1186/s40425-018-0445-4. Erratum in: J Immunother Cancer. 2019 Sep 2;7(1):234.

21.

The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children.

Lindoso L, Mondal K, Venkateswaran S, Somineni HK, Ballengee C, Walters TD, Griffiths A, Noe JD, Crandall W, Snapper S, Rabizadeh S, Rosh JR, LeLeiko N, Guthery S, Mack D, Kellermayer R, Gulati AS, Pfefferkorn MD, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley A, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Stephens MC, Baldassano R, Dubinsky MC, Markowitz J, Denson LA, Hyams J, Kugathasan S, Ananthakrishnan AN.

Am J Gastroenterol. 2018 Oct;113(10):1524-1529. doi: 10.1038/s41395-018-0239-9. Epub 2018 Sep 28.

PMID:
30267029
22.

Association of extracellular heat shock protein 70 and insulin resistance in type 2 diabetes; independent of obesity and C-reactive protein.

Alemi H, Khaloo P, Rabizadeh S, Mansournia MA, Mirmiranpour H, Salehi SS, Esteghamati A, Nakhjavani M.

Cell Stress Chaperones. 2019 Jan;24(1):69-75. doi: 10.1007/s12192-018-0942-x. Epub 2018 Sep 25.

23.

CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinoma.

Givechian KB, Garner C, Garban H, Rabizadeh S, Soon-Shiong P.

Oncotarget. 2018 Jul 3;9(51):29743-29752. doi: 10.18632/oncotarget.25701. eCollection 2018 Jul 3.

24.

TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes.

Würfel F, Erber R, Huebner H, Hein A, Lux MP, Jud S, Kremer A, Kranich H, Mackensen A, Häberle L, Hack CC, Rauh C, Wunderle M, Gaß P, Rabizadeh S, Brandl AL, Langemann H, Volz B, Nabieva N, Schulz-Wendtland R, Dudziak D, Beckmann MW, Hartmann A, Fasching PA, Rübner M.

Breast Care (Basel). 2018 Mar;13(1):8-14. doi: 10.1159/000486949. Epub 2018 Feb 15.

25.

Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples.

Givechian KB, Wnuk K, Garner C, Benz S, Garban H, Rabizadeh S, Niazi K, Soon-Shiong P.

NPJ Genom Med. 2018 Jun 13;3:14. doi: 10.1038/s41525-018-0054-7. eCollection 2018.

26.

Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles.

Chandradevan R, Hofmekler T, Mondal K, Harun N, Venkateswaran S, Somineni HK, Ballengee CR, Kim MO, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Walters TD, Bertha M, Dubinsky MC, Denson LA, Sauer CG, Markowitz JF, LeLeiko NS, Hyams JS, Kugathasan S.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2285-2290. doi: 10.1093/ibd/izy136.

PMID:
29860529
27.

Beneficial Effects of Pentoxifylline Plus Losartan Dual Therapy in Type 2 Diabetes with Nephropathy.

Rabizadeh S, Dehghani Firouzabadi F, Noshad S, Esteghamati S, Afarideh M, Ghajar A, Ganji M, Saadat M, Heidari B, Najafi MT, Nakhjavani M, Esteghamati A.

Am J Med Sci. 2018 May;355(5):442-448. doi: 10.1016/j.amjms.2017.12.015. Epub 2018 Feb 1.

PMID:
29753374
28.

Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer.

Rabizadeh S, Garner C, Sanborn JZ, Benz SC, Reddy S, Soon-Shiong P.

Oncotarget. 2018 Apr 10;9(27):19223-19232. doi: 10.18632/oncotarget.24973. eCollection 2018 Apr 10.

29.

Pulse pressure and diabetes treatments: Blood pressure and pulse pressure difference among glucose lowering modality groups in type 2 diabetes.

Alemi H, Khaloo P, Mansournia MA, Rabizadeh S, Salehi SS, Mirmiranpour H, Meftah N, Esteghamati A, Nakhjavani M.

Medicine (Baltimore). 2018 Feb;97(6):e9791. doi: 10.1097/MD.0000000000009791.

30.

New melanocortin-like peptide of E. coli can suppress inflammation via the mammalian melanocortin-1 receptor (MC1R): possible endocrine-like function for microbes of the gut.

Qiang X, Liotta AS, Shiloach J, Gutierrez JC, Wang H, Ochani M, Ochani K, Yang H, Rabin A, LeRoith D, Lesniak MA, Böhm M, Maaser C, Kannengiesser K, Donowitz M, Rabizadeh S, Czura CJ, Tracey KJ, Westlake M, Zarfeshani A, Mehdi SF, Danoff A, Ge X, Sanyal S, Schwartz GJ, Roth J.

NPJ Biofilms Microbiomes. 2017 Nov 13;3:31. doi: 10.1038/s41522-017-0039-9. eCollection 2017.

31.

Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.

Yoon SM, Haritunians T, Chhina S, Liu Z, Yang S, Landers C, Li D, Ye BD, Shih D, Vasiliauskas EA, Ippoliti A, Rabizadeh S, Targan SR, Melmed GY, McGovern DPB.

Inflamm Bowel Dis. 2017 Aug;23(8):1382-1393. doi: 10.1097/MIB.0000000000001150.

32.

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.

Ellsworth DL, Blackburn HL, Shriver CD, Rabizadeh S, Soon-Shiong P, Ellsworth RE.

Clin Transl Med. 2017 Dec;6(1):15. doi: 10.1186/s40169-017-0145-6. Epub 2017 Apr 12. Review.

33.

All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus.

Raee MR, Nargesi AA, Heidari B, Mansournia MA, Larry M, Rabizadeh S, Zarifkar M, Esteghamati A, Nakhjavani M.

Arch Iran Med. 2017 Mar;20(3):141-146. doi: 0172003/AIM.005.

34.

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.

Kugathasan S, Denson LA, Walters TD, Kim MO, Marigorta UM, Schirmer M, Mondal K, Liu C, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R, Kappelman MD, Steiner S, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley AR, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Trapnell BC, Sylvester FA, Stephens MC, Baldassano RN, Markowitz JF, Cho J, Xavier RJ, Huttenhower C, Aronow BJ, Gibson G, Hyams JS, Dubinsky MC.

Lancet. 2017 Apr 29;389(10080):1710-1718. doi: 10.1016/S0140-6736(17)30317-3. Epub 2017 Mar 2.

35.

An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele.

Jochems C, Hodge JW, Fantini M, Fujii R, Morillon YM 2nd, Greiner JW, Padget MR, Tritsch SR, Tsang KY, Campbell KS, Klingemann H, Boissel L, Rabizadeh S, Soon-Shiong P, Schlom J.

Oncotarget. 2016 Dec 27;7(52):86359-86373. doi: 10.18632/oncotarget.13411.

36.

Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients.

Dubinsky MC, Phan BL, Singh N, Rabizadeh S, Mould DR.

AAPS J. 2017 Jan;19(1):215-222. doi: 10.1208/s12248-016-9994-y. Epub 2016 Oct 13.

PMID:
27739008
37.

Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease.

Singh N, Rabizadeh S, Jossen J, Pittman N, Check M, Hashemi G, Phan BL, Hyams JS, Dubinsky MC.

Inflamm Bowel Dis. 2016 Sep;22(9):2121-6. doi: 10.1097/MIB.0000000000000865.

PMID:
27542130
38.

Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal Anastomosis.

Robbins L, Zaghiyan K, Melmed G, Vasiliauskas E, Ahmed S, McGovern D, Rabizadeh S, Singh N, Landers C, Ippoliti A, Shih D, Targan S, Fleshner P.

J Crohns Colitis. 2017 Jan;11(1):77-83. doi: 10.1093/ecco-jcc/jjw134. Epub 2016 Jul 27.

PMID:
27466172
39.

Real World Experience With Natalizumab at a Tertiary Care Pediatric IBD Center.

Singh N, Deshpande R, Rabizadeh S, Dubinsky M.

J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):863-6. doi: 10.1097/MPG.0000000000001089.

PMID:
27213249
40.

Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal Anastomosis.

Koh SZ, Zaghiyan KN, Li Q, Rabizadeh S, Melmed GY, Targan SR, Fleshner PR.

Inflamm Bowel Dis. 2016 Jun;22(6):1397-402. doi: 10.1097/MIB.0000000000000744.

PMID:
26978722
41.

Early infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel disease.

Singh N, Rosenthal CJ, Melmed GY, Mirocha J, Farrior S, Callejas S, Tripuraneni B, Rabizadeh S, Dubinsky MC.

Inflamm Bowel Dis. 2014 Oct;20(10):1708-13. doi: 10.1097/MIB.0000000000000137.

PMID:
25153505
42.

Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.

Dave B, Granados-Principal S, Zhu R, Benz S, Rabizadeh S, Soon-Shiong P, Yu KD, Shao Z, Li X, Gilcrease M, Lai Z, Chen Y, Huang TH, Shen H, Liu X, Ferrari M, Zhan M, Wong ST, Kumaraswami M, Mittal V, Chen X, Gross SS, Chang JC.

Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8838-43. doi: 10.1073/pnas.1320769111. Epub 2014 May 29.

43.

Stat3 activation in murine colitis induced by enterotoxigenic Bacteroides fragilis.

Wick EC, Rabizadeh S, Albesiano E, Wu X, Wu S, Chan J, Rhee KJ, Ortega G, Huso DL, Pardoll D, Housseau F, Sears CL.

Inflamm Bowel Dis. 2014 May;20(5):821-34. doi: 10.1097/MIB.0000000000000019.

44.

A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease.

Vahabnezhad E, Rabizadeh S, Dubinsky MC.

Inflamm Bowel Dis. 2014 Apr;20(4):606-13. doi: 10.1097/MIB.0000000000000003.

45.

Update in pediatric inflammatory bowel disease.

Rabizadeh S, Dubinsky M.

Rheum Dis Clin North Am. 2013 Nov;39(4):789-99. doi: 10.1016/j.rdc.2013.03.010. Epub 2013 Jul 17. Review.

46.

Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Hourigan SK, Chirumamilla SR, Ross T, Golub JE, Rabizadeh S, Saeed SA, Elson CO, Kelly CP, Carroll KC, Oliva-Hemker M, Sears C.

Inflamm Bowel Dis. 2013 Dec;19(13):2744-52. doi: 10.1097/01.MIB.0000435434.53871.36.

PMID:
24145927
47.

Label-free high-throughput cell screening in flow.

Mahjoubfar A, Chen C, Niazi KR, Rabizadeh S, Jalali B.

Biomed Opt Express. 2013 Aug 12;4(9):1618-25. doi: 10.1364/BOE.4.001618. eCollection 2013.

48.

Video capsule endoscopy impacts decision making in pediatric IBD: a single tertiary care center experience.

Min SB, Le-Carlson M, Singh N, Nylund CM, Gebbia J, Haas K, Lo S, Mann N, Melmed GY, Rabizadeh S, Dubinsky MC.

Inflamm Bowel Dis. 2013 Sep;19(10):2139-45. doi: 10.1097/MIB.0b013e31829a749c.

PMID:
23867872
49.

Distinct phenotypes of children with perianal perforating Crohn's disease.

Short SS, Dubinsky MC, Rabizadeh S, Farrior S, Berel D, Frykman PK.

J Pediatr Surg. 2013 Jun;48(6):1301-5. doi: 10.1016/j.jpedsurg.2013.03.027.

50.

Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM.

Sedgewick AJ, Benz SC, Rabizadeh S, Soon-Shiong P, Vaske CJ.

Bioinformatics. 2013 Jul 1;29(13):i62-70. doi: 10.1093/bioinformatics/btt229.

Supplemental Content

Loading ...
Support Center